Development of vaccines against COVID-19 hinges on “unprecedented” and transparent cooperation among industry, government, and academia, according to a commentary by Anthony Fauci, MD, and Francis Collins, MD, PhD, of the National Institutes of Health (NIH), and two other US vaccine experts published yesterday in Science. Noting that all vaccine platforms have advantages and disadvantages and underscoring the need for speed and flexibility of manufacture, safety, long-term efficacy, scale, affordability, vaccine stability, and a temperature-controlled supply chain, they said that “no single vaccine or vaccine platform alone is likely to meet the global need, and so a strategic approach to the multi-pronged endeavor is absolutely critical.”

 

Credit: National Institute of Allergy and Infectious Diseases (NIAID)

Read more CIDRAP…